314 related articles for article (PubMed ID: 25658762)
41. Epidemic O'Nyong-Nyong fever in southcentral Uganda, 1996-1997: entomologic studies in Bbaale village, Rakai District.
Lutwama JJ; Kayondo J; Savage HM; Burkot TR; Miller BR
Am J Trop Med Hyg; 1999 Jul; 61(1):158-62. PubMed ID: 10432073
[TBL] [Abstract][Full Text] [Related]
42. O'nyong-nyong fever: an epidemic virus disease in East Africa. VI. Alopecia in mice experimentally infected with o'nyong-nyong virus.
WALKER GM; WOODALL JP; HADDOW AJ; WILLIAMS MC
Trans R Soc Trop Med Hyg; 1962 Nov; 56():496-503. PubMed ID: 13998488
[No Abstract] [Full Text] [Related]
43. FHL1 is a major host factor for chikungunya virus infection.
Meertens L; Hafirassou ML; Couderc T; Bonnet-Madin L; Kril V; Kümmerer BM; Labeau A; Brugier A; Simon-Loriere E; Burlaud-Gaillard J; Doyen C; Pezzi L; Goupil T; Rafasse S; Vidalain PO; Bertrand-Legout A; Gueneau L; Juntas-Morales R; Ben Yaou R; Bonne G; de Lamballerie X; Benkirane M; Roingeard P; Delaugerre C; Lecuit M; Amara A
Nature; 2019 Oct; 574(7777):259-263. PubMed ID: 31554973
[TBL] [Abstract][Full Text] [Related]
44. The role of innate versus adaptive immune responses in a mouse model of O'nyong-nyong virus infection.
Seymour RL; Rossi SL; Bergren NA; Plante KS; Weaver SC
Am J Trop Med Hyg; 2013 Jun; 88(6):1170-9. PubMed ID: 23568285
[TBL] [Abstract][Full Text] [Related]
45. O'nyong nyong virus molecular determinants of unique vector specificity reside in non-structural protein 3.
Saxton-Shaw KD; Ledermann JP; Borland EM; Stovall JL; Mossel EC; Singh AJ; Wilusz J; Powers AM
PLoS Negl Trop Dis; 2013; 7(1):e1931. PubMed ID: 23359824
[TBL] [Abstract][Full Text] [Related]
46. Emergence of chikungunya seropositivity in healthy Malaysian adults residing in outbreak-free locations: chikungunya seroprevalence results from the Malaysian Cohort.
Azami NA; Salleh SA; Shah SA; Neoh HM; Othman Z; Zakaria SZ; Jamal R
BMC Infect Dis; 2013 Feb; 13():67. PubMed ID: 23379541
[TBL] [Abstract][Full Text] [Related]
47. Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergence.
Fischer C; Bozza F; Merino Merino XJ; Pedroso C; de Oliveira Filho EF; Moreira-Soto A; Schwalb A; de Lamballerie X; Netto EM; Bozza PT; Sarno M; Brites C; Gotuzzo E; Talledo M; Drexler JF
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024703
[TBL] [Abstract][Full Text] [Related]
48. Quercetin can reduce viral RNA level of O'nyong-nyong virus and resulting innate immune cytokine responses in cultured human synovial fibroblasts.
Septembre-Malaterre A; Bedoui Y; Giry C; Gasque P; Guiraud P; Sélambarom J
Sci Rep; 2021 Mar; 11(1):6369. PubMed ID: 33737658
[TBL] [Abstract][Full Text] [Related]
49. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency.
Warter L; Lee CY; Thiagarajan R; Grandadam M; Lebecque S; Lin RT; Bertin-Maghit S; Ng LF; Abastado JP; Desprès P; Wang CI; Nardin A
J Immunol; 2011 Mar; 186(5):3258-64. PubMed ID: 21278338
[TBL] [Abstract][Full Text] [Related]
50. Seroprevalence and entomological study on Chikungunya virus at the Croatian littoral.
Vilibic-Cavlek T; Pem-Novosel I; Kaic B; Babić-Erceg A; Kucinar J; Klobucar A; Medic A; Pahor D; Barac-Juretic K; Gjenero-Margan I
Acta Microbiol Immunol Hung; 2015 Jun; 62(2):199-206. PubMed ID: 26132839
[TBL] [Abstract][Full Text] [Related]
51. Bibliometric study of international scientific production in O'nyong-Nyong virus during the years 1962-2016.
Rios-González CM
J Infect Public Health; 2017; 10(1):137-138. PubMed ID: 27296554
[No Abstract] [Full Text] [Related]
52. Follow-Up Household Serosurvey in Northeast Brazil for Zika Virus: Sexual Contacts of Index Patients Have the Highest Risk for Seropositivity.
Magalhaes T; Morais CNL; Jacques IJAA; Azevedo EAN; Brito AM; Lima PV; Carvalho GMM; Lima ARS; Castanha PMS; Cordeiro MT; Oliveira ALS; Jaenisch T; Lamb MM; Marques ETA; Foy BD
J Infect Dis; 2021 Feb; 223(4):673-685. PubMed ID: 32888023
[TBL] [Abstract][Full Text] [Related]
53. Broad-spectrum monoclonal antibodies against chikungunya virus structural proteins: Promising candidates for antibody-based rapid diagnostic test development.
Tuekprakhon A; Puiprom O; Sasaki T; Michiels J; Bartholomeeusen K; Nakayama EE; Meno MK; Phadungsombat J; Huits R; Ariën KK; Luplertlop N; Shioda T; Leaungwutiwong P
PLoS One; 2018; 13(12):e0208851. PubMed ID: 30557365
[TBL] [Abstract][Full Text] [Related]
54. Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships.
Powers AM; Brault AC; Tesh RB; Weaver SC
J Gen Virol; 2000 Feb; 81(Pt 2):471-9. PubMed ID: 10644846
[TBL] [Abstract][Full Text] [Related]
55. Malaria abrogates O'nyong-nyong virus pathologies by restricting virus infection in nonimmune cells.
Torres-Ruesta A; Teo TH; Chan YH; Amrun SN; Yeo NK; Lee CY; Nguee SY; Tay MZ; Nosten F; Fong SW; Lum FM; Carissimo G; Renia L; Ng LF
Life Sci Alliance; 2022 Apr; 5(4):. PubMed ID: 35039441
[TBL] [Abstract][Full Text] [Related]
56. Standardization of ELISA for anti-chikungunya-IgG antibodies and age-stratified prevalence of anti-chikungunya-IgG antibodies in Pune, India.
Patil HP; Rane PS; Gosavi M; Mishra AC; Arankalle VA
Eur J Clin Microbiol Infect Dis; 2020 Oct; 39(10):1925-1932. PubMed ID: 32504313
[TBL] [Abstract][Full Text] [Related]
57. Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection.
Kishishita N; Takeda N; Anuegoonpipat A; Anantapreecha S
J Clin Microbiol; 2013 May; 51(5):1389-95. PubMed ID: 23408687
[TBL] [Abstract][Full Text] [Related]
58. Species-specific MARCO-alphavirus interactions dictate chikungunya virus viremia.
Li FS; Carpentier KS; Hawman DW; Lucas CJ; Ander SE; Feldmann H; Morrison TE
Cell Rep; 2023 May; 42(5):112418. PubMed ID: 37083332
[TBL] [Abstract][Full Text] [Related]
59. O'NYONG-NYONG FEVER: AN EPIDEMIC VIRUS DIESEASE IN EAST AFRICA. VII. VIRUS ISOLATIONS FROM MAN AND SEROLOGICAL STUDIES UP TO JULY 1961.
WILLIAMS MC; WOODALL JP; GILLETT JD
Trans R Soc Trop Med Hyg; 1965 Mar; 59():186-97. PubMed ID: 14297194
[No Abstract] [Full Text] [Related]
60. Serological and spatial analysis of alphavirus and flavivirus prevalence and risk factors in a rural community in western Kenya.
Grossi-Soyster EN; Cook EAJ; de Glanville WA; Thomas LF; Krystosik AR; Lee J; Wamae CN; Kariuki S; Fèvre EM; LaBeaud AD
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005998. PubMed ID: 29040262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
